Reg3g overexpression promotes β cell regeneration and induces immune tolerance in nonobese-diabetic mouse model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reg3g overexpression promotes β cell regeneration and induces immune tolerance in nonobese-diabetic mouse model

Published:2015-12-14 Issue:6 Volume:99 Page:1131-1140
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Xia Fei,Cao Hui,Du Jiao,Liu Xiulan,Liu Yang,Xiang Ming

Funder

National Natural Science Foundation of China

University of Rhode Island

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1189/jlb.3A0815-371RRR/fullpdf

Reference47 articles.

1. Genetics, pathogenesis and clinical interventions in type 1 diabetes;Bluestone;Nature,2010

2. Islet transplantation from a nationally funded UK centre reaches socially deprived groups and improves metabolic outcomes;Forbes;Diabetologia,2015

3. The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials;Dżygało;Acta Diabetol.,2015

4. Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes;Haller;J. Clin. Invest.,2015

5. A novel gene activated in regenerating islets;Terazono;J. Biol. Chem.,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the osteoblastic HIF-1α pathway partially alleviates the symptoms of STZ-induced type 1 diabetes mellitus via RegIIIγ;Experimental & Molecular Medicine;2024-07-01

2. Latest advancements in the development of new therapies for type 1 diabetes;Bratislava Medical Journal;2024

3. Current Research Status of Regenerating Protein (Reg) Family in Diabetes Mellitus;Advances in Clinical Medicine;2024

4. Stem cells therapy for diabetes: from past to future;Cytotherapy;2023-11

5. Reg3γ: current understanding and future therapeutic opportunities in metabolic disease;Experimental & Molecular Medicine;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3